HENDERSON MICHAEL THOMAS (CIK 1779990) reported 43 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-10). Recent activity: Sell APGE (20,000 shares), Sell APGE (75,046 shares), Sell APGE (80,000 shares), Sell SYRE (20,000 shares), Sell APGE (6,770 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 20,000 | $2.7M |
| 2026-07-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 75,046 | $0 |
| 2026-06-24 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 80,000 | $10.6M |
| 2026-06-23 | Spyre Therapeutics, Inc. (SYRE) | Director | Sell | 20,000 | $2.0M |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 6,770 | $556,562 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 7,654 | $633,598 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 1,080 | $90,914 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 1,577 | $134,345 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 2,305 | $198,852 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 614 | $53,350 |
| 2026-05-15 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 18,659 | $1.5M |
| 2026-05-15 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 1,341 | $110,740 |
| 2026-05-08 | Spyre Therapeutics, Inc. (SYRE) | Director | Sell | 2,404 | $174,458 |
| 2026-05-08 | Spyre Therapeutics, Inc. (SYRE) | Director | Sell | 33,513 | $2.5M |
| 2026-05-08 | Spyre Therapeutics, Inc. (SYRE) | Director | Sell | 24,814 | $1.9M |
| 2026-05-08 | Spyre Therapeutics, Inc. (SYRE) | Director | Sell | 19,269 | $1.5M |
| 2026-04-20 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Buy | 3,000 | $68,580 |
| 2026-04-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 17,800 | $1.5M |
| 2026-04-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 2,000 | $166,520 |
| 2026-04-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 200 | $17,000 |
| 2026-03-13 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 8,363 | $621,287 |
| 2026-03-13 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 8,219 | $615,028 |
| 2026-03-13 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 3,418 | $259,289 |
| 2026-02-13 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 11,494 | $723,662 |
| 2026-02-13 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | Sell | 7,551 | $481,225 |
Source: SEC Form 4 filings · as of 2026-07-10